Shanghai Bio-Heart Biological Technology Co., Ltd. Class H Revenue
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H had a revenue of 23.67M in the quarter ending Dec 31, 2025, with 13.45%. This bring the company's revenue in the last twelve months to 44.53M, Decreased 113.45%. In the fiscal year ending Dec 31, 2025, Shanghai Bio-Heart Biological Technology Co., Ltd. Class H had annual revenue of 43.77M with Infinity% growth.